Lactobacillus reuteri UALre-16 and Reduced Interleukin-1β Levels

• The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial

  • 2018-11-14
  • RCT · n = 68
  • Scientific Reports 8(1)
  • • M. Hsieh
    • W. Tsai
    • Yu-Pang Jheng
    • S. Su
    • Shu-Yi Wang
    • Chi-Chen Lin
    • Yi-Hsing Chen
    • Wen-Wei Chang

  • PubMed: 30429496
  • DOI: 10.1038/s41598-018-35014-1

  13 Insights on

  • Reduced Interleukin-1β Levels

  • High evidence
  • Highly Cited
  • Rigorous Journal

  There was no obvious change in serum inflammatory cytokines or antioxidant proteins in participants after intaking ADR-1 or ADR-3, except for a reduction in IL-1β in the ADR-3 consumption group after 6 months of intake.

  Effect

  Beneficial

  Effect size

  Small